Resetting Immune Dysfunction: A New Approach to Treat ALS (ft. Dr. Ronald Lane)

In this episode, we're honored to welcome Dr. Ronald Lane, CEO of HOPE-Neuron Therapeutx. Dr. Lane is currently conducting research into a novel and innovative way to treat ALS.Tune in to hear about the research being conducted by Dr. Lane and his team into neuroimmune modulation, HOPE-Neuron Therapeutx's mission, as well as possible implications for ALS patients and the field of healthcare is Dr. Lane's research and in-human trials are successful.